News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25
Sara Tolaney and Kevin Kalinsky
Mar 11, 2025, 13:39

Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25

Nirmit Kumar, Senior Global Medical Strategy Leader at AstraZeneca, shared a post on X:

“Excellent debate on the benefit of chemo in premenopausal patients with Recurrence Score (RS) ≤ 25 between Sara Tolaney and Kevin Kalinsky.

Tolerability of ovarian function suppression varies so adjuvant chemotherapy usually recommended depending on patient’s clinical profile.”

Nirmit Kumar: Excellent debate on the benefit of chemo in premenopausal patients with RS ≤ 25

AstraZeneca cancer fight against cancer Global fight against cancer Kevin Kalinsky Nirmit Kumar OncoDaily Oncology Sara Tolaney
Special Coverage
Blog
Apr 18, 2025, 20:22
Applications are open for the ESMO Research Fellowship
Blog
Apr 18, 2025, 20:12
Caitríona Duggan: Delighted for the opportunity to share our work at MASCC
Blog
Apr 18, 2025, 20:03
Fumiko Ladd Chino: Honored to be invited to speak about financial toxicity
Blog
Apr 18, 2025, 20:02
Estelamari Rodriguez: ACS NLCRT Biomarker Workshop version of brainstorming with the stars
Blog
Apr 18, 2025, 19:54
Sami Mansfield: Fiber, the microbiome, and cancer care
Blog
Apr 18, 2025, 19:49
Eric K. Singhi Discusses Lung Cancer at ASCO 2025
Science
Apr 18, 2025, 19:44
Nirmala Bhoo Pathy: The need for race and ethnicity data in cancer control
Science
Apr 18, 2025, 19:28
Andreas Charalambous: Achieving digital transformation in cancer care across Europe
Blog
Apr 18, 2025, 19:26
SIOG - Older adults deserve better: Let’s close the gap in Cancer Care
Science
Apr 18, 2025, 19:10
Rafael Grochot: The safety and activity of FGFR inhibitors in early-phase clinical trials
Blog
Apr 18, 2025, 18:58
Mission Adaptation and Mission Cancer: Resilient Health Systems for Cancer - ECHoS
Blog
Apr 18, 2025, 18:55
Robert F. Kennedy Jr. visited U.S. FDA with Commissioner Martin Makary on Medical Innovation